Imprimer

1,8-Dihydroxyanthracène-9(10H)-one ≥99%, poudre jaune

Marques : MP Biomedicals
Ratings: Ecrire un avis

Total Evaluation: 0
Moyenne des Notes : 0.0 sur 5

Attention

0219150294 0219150283 0219150291
ICNA0219150294EA 473 EUR
ICNA0219150294 ICNA0219150283 ICNA0219150291
1,8-Dihydroxyanthracène-9(10H)-one ≥99%, poudre jaune
1,8-Dihydroxyanthracène-9(10H)-one

Dithranol (1, 8 - dihydroxy-9-anthrone) is also known as anthralin. It is a vital topical antipsoriatic drugs. Dithranol, an athracene derivative, is a free radical generating mitochondrial poison that induces apoptosis in keratinocytes.


Dithranol, a potential anti-psoriasis medication, may be used to study its safety, efficacy, metabolism and pharmacological profile. Dithranol may be used to study is physicochemical properties, as a reference compound and to develop effective drug delivery vehicles. Dithranol may be used as a matrix for matrix assisted laser desorption/ionization imaging on a Fourier transform ion cyclotron resonance mass spectrometer.


Dithranol, an athracene derivative, is a free radical generating mitochondrial poison that induces apoptosis in keratinocytes. Dithranol is being studied as a potential anti-psoriasis medication.


Soluble in chlororform (20 mg/ml - clear, bright yellow solution) and in fixed oilds; slightly soluble in ethanol (95%) and in ether; practically insoluble in water.

Formule: C₁₄H₁₀O₃
Point d'ébullition: 400 °C (1013 hPa)
Point de fusion: 193,5 - 195 °C
Densité: 1,433 g/cm³ (20 °C)
Température de stockage: Température ambiante
Numéro MDL: MFCD00053409
Numéro CAS: 1143-38-0
EINECS: 214-538-0
Indice Merck: 12,00723

Commander maintenant

Résultats des tests de spécification

Identity Test Passes
Purity ≥99%
FTIR Conforms to Standard
Melting Point 175 - 182°C


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Plus About VWR